HANARO BIO KOREA ACTIVEHANARO BIO KOREA ACTIVEHANARO BIO KOREA ACTIVE

HANARO BIO KOREA ACTIVE

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪68.87 M‬KRW
Fund flows (1Y)
‪−11.15 M‬KRW
Dividend yield (indicated)
Discount/Premium to NAV
−0.3%
Shares outstanding
‪7.00 K‬
Expense ratio

About HANARO BIO KOREA ACTIVE


Brand
NH-Amundi
Home page
Inception date
Nov 26, 2024
Index tracked
No Underlying Index
Management style
Active
Dividend treatment
Distributes
Primary advisor
NH-Amundi Asset Management Co., Ltd.
ISIN
KR7498050004

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Geography
South Korea

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of April 9, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.53%
Health Technology93.59%
Health Services3.76%
Technology Services2.18%
Bonds, Cash & Other0.47%
Cash0.47%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows